AP Biosciences Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	14,120	4,223	3,017	-
Market Cap Growth	209.96%	39.97%	-	-
Enterprise Value	12,908	2,559	2,131	-
Last Close Price	165.00	49.75	46.60	-
PS Ratio	-	-	93.55	-
PB Ratio	10.56	2.60	3.85	-
P/TBV Ratio	10.58	2.61	3.87	-
EV/Sales Ratio	-	-	66.08	-
Debt / Equity Ratio	0.05	0.04	0.11	-
Net Debt / Equity Ratio	-0.91	-0.91	-0.84	-0.98
Net Debt / EBITDA Ratio	2.71	3.39	1.91	3.72
Net Debt / FCF Ratio	3.17	4.05	1.98	3.89
Asset Turnover	-	-	0.03	-
Quick Ratio	18.49	39.77	24.77	241.91
Current Ratio	18.55	39.87	24.80	242.10
Return on Equity (ROE)	-	-35.13%	-36.04%	-
Return on Assets (ROA)	-	-20.96%	-21.78%	-
Return on Capital Employed (ROCE)	-32.90%	-26.00%	-40.40%	-27.10%
Earnings Yield	-3.17%	-10.01%	-11.24%	-
FCF Yield	-2.71%	-8.61%	-11.03%	-
Buyback Yield / Dilution	-21.09%	-16.28%	-22.98%	-

Source: S&P Capital IQ. Standard template. Financial Sources.